Clinical Trial

Generation of Cell Banks and Biomarker Isolation From Patients With Amyotrophic Lateral Sclerosis (ALS) (HCD-SLA)

Name: Generation of Cell Banks and Biomarker Isolation From Patients With Amyotrophic Lateral Sclerosis (ALS) (HCD-SLA) — clinical trial record (NCT07099066)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: HCD-SLA

Not Yet Recruiting

View on ClinicalTrials.gov →

Record status

This record was last updated August 1, 2025 (before its estimated April 2026 completion). Its status may not reflect the trial's current state.

Summary

The aim of this research is to establish different cell banks from patients with amyotrophic lateral sclerosis (ALS).

Trial Details

NCT Number	NCT07099066
Lead Sponsor	Human Cell Design
Conditions	Amyotrophic Lateral Sclerosis (ALS)
Enrollment	50 participants
Start Date	2025-09-01
Primary Completion	2026-04 (estimated)
Study Completion	2026-06 (estimated)
Updated on ClinicalTrials.gov	2025-08-01